Tina Sampath has been promoted to Interim CEO

We are pleased to announce that Tina Sampath has been promoted to Interim CEO. Tina joined Cumulus Neuroscience as CCO in 2023 and was charged with driving growth for the company’s first product, the NeuLogiq™ Neuro-Assessment Platform. Tina assumed the role of Interim CEO this month and is responsible for driving the continued growth of NeuLogiq™ while fundraising and overseeing commercialization planning to support development of the company’s second product AccelADx™.